SCHEMBL6317067

SCHEMBL6317067

CCCCC/C(=C/C(=O)O)Nc1ccc(NC(C)=O)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 2/20 0.47
▸ RECQL P46063 1/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ SOAT2 O75908 1/20 0.45
▸ SOAT1 P35610 1/20 0.45
▸ THRA P10827 1/20 0.44
▸ THRB P10828 1/20 0.44
▸ PSMB11 A5LHX3 1/20 0.44
▸ PSMA7 O14818 1/20 0.44
▸ PSMB1 P20618 1/20 0.44
▸ PSMA1 P25786 1/20 0.44
▸ PSMA2 P25787 1/20 0.44
▸ PSMA3 P25788 1/20 0.44
▸ PSMA4 P25789 1/20 0.44
▸ PSMB8 P28062 1/20 0.44
▸ PSMB9 P28065 1/20 0.44
▸ PSMA5 P28066 1/20 0.44
▸ PSMB4 P28070 1/20 0.44
▸ PSMB6 P28072 1/20 0.44
▸ PSMB5 P28074 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6317063 1.00 HPGD (0.47) HPGDRECQLSMN1; SMN2SOAT2SOAT1
SCHEMBL6317070 1.00 HPGD (0.47) HPGDRECQLSMN1; SMN2SOAT2SOAT1
SCHEMBL4255254 0.89 SMN1; SMN2 (0.47) HPGDSMN1; SMN2HTTL3MBTL1NAPRT
SCHEMBL4255261 0.89 SMN1; SMN2 (0.47) HPGDSMN1; SMN2HTTL3MBTL1NAPRT
SCHEMBL4255264 0.89 SMN1; SMN2 (0.47) HPGDSMN1; SMN2HTTL3MBTL1NAPRT
SCHEMBL21065463 0.87 SOAT2 (0.59) SOAT2SOAT1HTTALDH1A1ICMT
SCHEMBL21065474 0.87 SOAT2 (0.59) SOAT2SOAT1HTTALDH1A1ICMT
SCHEMBL5581863 0.83 SMN1; SMN2 (0.50) HPGDSMN1; SMN2HTTL3MBTL1NAPRT
SCHEMBL10472081 0.76 ALDH1A1 (0.54) HPGDRECQLSMN1; SMN2SOAT2SOAT1
SCHEMBL25730771 0.76 THRA (0.52) THRATHRBCA1CA2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009815-A1 4-Aminoquinoline compounds DEVITA ROBERT J (US) 2005-01-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009815-A1 4-Aminoquinoline compounds MCHR1, MCHR2, MC5R HPGD 2197/4885RECQL 530/4885SMN1; SMN2 201/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback